Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Confirmation of earnings
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(98)
•••
Comment by Thisguyiscoolon Aug 14, 2020 7:49am
150 Views
Post# 31407201

RE:RE:RE:RE:RE:Confirmation of earnings

RE:RE:RE:RE:RE:Confirmation of earnings
StageZero Announces Second Quarter Analyst and Investor Call 8/14/2020 TORONTO, ON / ACCESSWIRE / August 14, 2020 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its Second Quarter 2020 operational results after market close on Friday, August 14, 2020. StageZero's Chairman and CEO, James R Howard-Tripp, will host a conference call and online presentation at 8:30 am ET on Monday August 17th to review the operational results and discuss business developments for the period and to date. Analyst and Investor Call Event Date: Monday August 17, 2020 Time: 8:30 AM EST Webcast Link: https://www.webcaster4.com/Webcast/Page/2082/36633 Participant Numbers: Toll Free: 844-369-8770 International: 862-298-0840 Replay Number: Toll Free: 877-481-4010 International: 919-882-2331 Replay Passcode: 36633 About StageZero Life Sciences, Ltd.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities